561 related articles for article (PubMed ID: 9028724)
21. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
Van der Auwera BJ; Vandewalle CL; Schuit FC; Winnock F; De Leeuw IH; Van Imschoot S; Lamberigts G; Gorus FK
Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
[TBL] [Abstract][Full Text] [Related]
23. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
24. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
25. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
26. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
[TBL] [Abstract][Full Text] [Related]
27. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
28. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
[TBL] [Abstract][Full Text] [Related]
29. Relation between antibodies to islet cell antigens, other autoantigens and cow's milk proteins in diabetic children and unaffected siblings at the clinical manifestation of IDDM. The Childhood Diabetes in Finland Study Group.
Vähäsalo P; Petäys T; Knip M; Miettinen A; Saukkonen T; Karjalainen J; Savilahti E; Akerblom HK
Autoimmunity; 1996; 23(3):165-74. PubMed ID: 8879452
[TBL] [Abstract][Full Text] [Related]
30. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
[TBL] [Abstract][Full Text] [Related]
31. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
32. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
35. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
[TBL] [Abstract][Full Text] [Related]
36. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
37. Genetic and immunological markers of insulin dependent diabetes in Black Americans.
Leech NJ; Kitabchi AE; Gaur LK; Hagopian WA; Hansen J; Burghen GA; Palmer JP; Nepom GT
Autoimmunity; 1995; 22(1):27-32. PubMed ID: 8882419
[TBL] [Abstract][Full Text] [Related]
38. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
[TBL] [Abstract][Full Text] [Related]
39. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
[TBL] [Abstract][Full Text] [Related]
40. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
